fox worning chicen, page-13

"What, are your thoughts on profit or loss for 2013-2014 financial year?"

Indi, let's wait and see what else pops up next month and the months after that. Then we add in Sanofi payments, Hikma payments and development payments along the way. Why would anyone want to short change the company's recent achievements by putting the end of financial year as the discussion point?, especially when we know supply will be ramping up at/around that point so pigeonholing earnings potential to just the current financial year seems wrong in a forward looking market.

The company has only just started to sign the must anticipated supply and development agreements in the last few months, the financial year is half over and we haven't seen half of what we were told is coming.